Volume: 38 Issue: 1

1. Changes of diagnosis and treatment strategies of retinal vein occlusion according to EURETINA updated guidelines Page:1—3
2. Inhibitory effects of NADPH oxidase 4 inhibitor on VEGF expression in hypoxia-induced human RPE cells Page:4—9
3. Damage of blue-light exposure to retinal morphology and function in mice Page:10—15
4. Antioxidative effect and mechanism of tert-butyl hydroquinone on rat retinal Müller cells under high glucose condition Page:16—22
5. Protective effects of folic acid on retina in diabetic mice and its anti-oxidative stress mechanism Page:23—30
6. Regulation and its mechanism of MeCP2 on biological behavior and epithelial-mesenchymal transition of LECs Page:32—37
7. Inhibitory effect of small interfering RNA-TLR9 on high glucose-induced retinal ganglion cell apoptosis Page:38—44
8. Unraveling the genetic cause of juvenile neuronal ceroid-lipofuscinosis Page:45—49
9. Comparision of the clinical effects on vitrectomy with or without fovea-sparing internal limiting membrane peeling Page:50—54
10. Spectral domain OCT for the differentiation of polypoidal choroidal vasculopathy from wet age-related macular degeneration Page:55—59
11. Interpretation of the 2019 Guidelines for the Management of retinal vein occlusion by the EURETINA Page:60—63
12. Neuroprotective effect of vascular endothelial growth factor Page:64—67
13. Effects of complement dysfunction on diabetic retinopathy Page:68—72
14. Anti-apoptotic mechanism of heme oxygenase 1 and its protective role in related ophthalmopathy Page:73—76
15. Treatment on retinopathy of prematurity Page:77—80
16. Changes of diagnosis and treatment strategies of retinal vein occlusion according to EURETINA updated guidelines Page:1—3
17. Inhibitory effects of NADPH oxidase 4 inhibitor on VEGF expression in hypoxia-induced human RPE cells Page:4—9
18. Damage of blue-light exposure to retinal morphology and function in mice Page:10—15
19. Antioxidative effect and mechanism of tert-butyl hydroquinone on rat retinal Müller cells under high glucose condition Page:16—22
20. Protective effects of folic acid on retina in diabetic mice and its anti-oxidative stress mechanism Page:23—30
21. Regulation and its mechanism of MeCP2 on biological behavior and epithelial-mesenchymal transition of LECs Page:32—37
22. Inhibitory effect of small interfering RNA-TLR9 on high glucose-induced retinal ganglion cell apoptosis Page:38—44
23. Unraveling the genetic cause of juvenile neuronal ceroid-lipofuscinosis Page:45—49
24. Comparision of the clinical effects on vitrectomy with or without fovea-sparing internal limiting membrane peeling Page:50—54
25. Spectral domain OCT for the differentiation of polypoidal choroidal vasculopathy from wet age-related macular degeneration Page:55—59
26. Interpretation of the 2019 Guidelines for the Management of retinal vein occlusion by the EURETINA Page:60—63
27. Neuroprotective effect of vascular endothelial growth factor Page:64—67
28. Effects of complement dysfunction on diabetic retinopathy Page:68—72
29. Anti-apoptotic mechanism of heme oxygenase 1 and its protective role in related ophthalmopathy Page:73—76
30. Treatment on retinopathy of prematurity Page:77—80